Woodstock Corp Reduces Stock Holdings in CVS Health Corporation $CVS

Woodstock Corp cut its holdings in shares of CVS Health Corporation (NYSE:CVS) by 25.8% in the third quarter, HoldingsChannel reports. The firm owned 30,219 shares of the pharmacy operator’s stock after selling 10,483 shares during the period. Woodstock Corp’s holdings in CVS Health were worth $2,278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Cantor Fitzgerald Investment Advisors L.P. grew its holdings in CVS Health by 1.6% during the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after acquiring an additional 6,615 shares during the period. Red Mountain Financial LLC purchased a new stake in CVS Health in the 2nd quarter worth approximately $293,000. AE Wealth Management LLC grew its stake in shares of CVS Health by 607.5% during the 2nd quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock worth $16,708,000 after purchasing an additional 207,984 shares during the period. Vanguard Group Inc. increased its holdings in shares of CVS Health by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after purchasing an additional 2,063,737 shares in the last quarter. Finally, WBI Investments LLC boosted its holdings in CVS Health by 388.3% during the first quarter. WBI Investments LLC now owns 73,562 shares of the pharmacy operator’s stock worth $4,984,000 after buying an additional 58,496 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

NYSE CVS opened at $78.34 on Wednesday. The company has a market cap of $99.45 billion, a P/E ratio of 206.17, a P/E/G ratio of 0.79 and a beta of 0.48. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The stock has a 50-day moving average of $79.05 and a two-hundred day moving average of $72.20.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

Wall Street Analyst Weigh In

CVS has been the subject of several recent analyst reports. Argus lifted their price target on CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Raymond James Financial increased their target price on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Jefferies Financial Group upped their price objective on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. The Goldman Sachs Group raised their target price on CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Finally, Robert W. Baird increased their price objective on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $93.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.